Corteva, Inc. (NYSE:CTVA) Shares Purchased by Ossiam

Ossiam boosted its position in shares of Corteva, Inc. (NYSE:CTVA) by 4,274.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,052 shares of the company’s stock after acquiring an additional 204,273 shares during the quarter. Ossiam’s holdings in Corteva were worth $11,908,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CTVA. Capital World Investors boosted its holdings in Corteva by 2,874.6% in the fourth quarter. Capital World Investors now owns 12,812,151 shares of the company’s stock valued at $729,780,000 after purchasing an additional 12,381,436 shares during the period. Independent Franchise Partners LLP raised its position in Corteva by 51.5% in the 4th quarter. Independent Franchise Partners LLP now owns 16,496,508 shares of the company’s stock valued at $939,641,000 after purchasing an additional 5,604,838 shares in the last quarter. Norges Bank purchased a new position in shares of Corteva in the 4th quarter valued at about $251,892,000. Raymond James Financial Inc. acquired a new position in shares of Corteva during the fourth quarter worth about $161,052,000. Finally, Franklin Resources Inc. increased its stake in shares of Corteva by 9.2% during the fourth quarter. Franklin Resources Inc. now owns 16,143,025 shares of the company’s stock worth $919,507,000 after buying an additional 1,354,418 shares during the period. 81.54% of the stock is owned by institutional investors and hedge funds.

Corteva Price Performance

CTVA stock opened at $59.69 on Friday. The company has a current ratio of 1.45, a quick ratio of 0.93 and a debt-to-equity ratio of 0.08. The company has a market capitalization of $40.77 billion, a P/E ratio of 46.27, a PEG ratio of 1.68 and a beta of 0.73. The business has a 50 day simple moving average of $60.97 and a 200-day simple moving average of $60.28. Corteva, Inc. has a twelve month low of $50.01 and a twelve month high of $66.24.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Wednesday, February 5th. The company reported $0.32 earnings per share for the quarter, missing analysts’ consensus estimates of $0.34 by ($0.02). Corteva had a return on equity of 7.19% and a net margin of 5.36%. As a group, equities analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 1.14%. The ex-dividend date was Monday, March 3rd. Corteva’s dividend payout ratio is presently 52.71%.

Wall Street Analyst Weigh In

A number of brokerages recently issued reports on CTVA. Wells Fargo & Company lifted their price target on shares of Corteva from $67.00 to $73.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 28th. Royal Bank of Canada lifted their price objective on shares of Corteva from $72.00 to $73.00 and gave the stock an “outperform” rating in a research report on Friday, February 7th. Citigroup increased their target price on Corteva from $69.00 to $74.00 and gave the company a “buy” rating in a report on Wednesday, January 29th. Bank of America lifted their price target on Corteva from $69.00 to $73.00 and gave the stock a “buy” rating in a report on Tuesday, February 11th. Finally, KeyCorp increased their price objective on Corteva from $70.00 to $71.00 and gave the company an “overweight” rating in a report on Monday, April 14th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $68.13.

Insiders Place Their Bets

In other Corteva news, insider Brian Titus sold 26,560 shares of the company’s stock in a transaction on Thursday, February 20th. The shares were sold at an average price of $63.74, for a total transaction of $1,692,934.40. Following the completion of the transaction, the insider now owns 11,347 shares in the company, valued at approximately $723,257.78. This represents a 70.07 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.14% of the stock is owned by insiders.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.